The impact of cellular environment on in vitro drug screening

Aiman Moldasheva1, Laura Bakyt1, Denis Bulanin1

  • 1Department of Biomedical Science, Nazarbayev University School of Medicine, Astana, 010000, Kazakhstan.

Future Science OA
|September 27, 2023
PubMed

Insights

Drug screening in cell cultures often fails due to differences between lab systems and whole organisms. Incorporating microenvironmental and pharmacomechanical factors improves accuracy for better drug development.

Area of Science:

  • Pharmacology and Toxicology
  • Cell Biology
  • Biomedical Engineering

Background:

  • Drug development faces high failure rates due to toxicity, adverse effects, and inefficacy.
  • Existing cell culture models do not fully replicate the complex in vivo environment, leading to inaccurate predictions.
  • Human phenotypical cells offer relevance but can yield false positives due to microenvironmental influences.

Purpose of the Study:

  • To highlight the limitations of current cell culture models in predicting drug efficacy.
  • To emphasize the necessity of considering microenvironmental and pharmacomechanical factors in drug screening.
  • To advocate for more sophisticated tissue culture systems for improved drug development outcomes.

Main Methods:

  • Review of existing literature on drug development failures and cell culture methodologies.
  • Analysis of the impact of microenvironmental stimuli on cellular responses.
  • Discussion of pharmacomechanical principles in the context of tissue engineering and drug testing.

Main Results:

  • Cellular responses in vitro are significantly modulated by the surrounding microenvironment.
  • Pharmacomechanical forces play a crucial role in drug-target interactions and cellular behavior.
  • Current screening methods may overestimate or underestimate drug efficacy due to these unaddressed factors.

Conclusions:

  • Accurate drug screening requires models that recapitulate the complex interplay of cellular and microenvironmental factors.
  • Integrating microenvironmental and pharmacomechanical considerations into tissue culture drug screening is essential for reducing late-stage drug failure.
  • Future drug development should leverage advanced in vitro models that better mimic in vivo conditions.